Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
p-tert-butylphenol-formaldehyde resin (low molecular weight) is a synthetic thermosetting polymer formed by the condensation of 4-tert-butylphenol and formaldehyde. It is primarily used as an adhesive in various commercial products and industrial applications due to its strong bonding properties, heat resistance, chemical stability, and water resistance[3][8]. Medically, it is recognized as a standardized chemical allergen and dermatological sensitizer; exposure can cause allergic contact dermatitis in susceptible individuals. Its mechanism of action as an allergen involves increased histamine release and cell-mediated immunity responses when used in clinical patch testing for allergy diagnosis[3][4][6]. The compound has been approved for use in diagnostic patch tests such as the T.R.U.E. Test.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on p-tert-butylphenol-formaldehyde resin (low molecular weight).